Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial

by Azarbarzin, A., Lombardi, C., Marconi, M., Meriggi, P., Parati, G., Perger, E., Rosa, D., Sands, S.A, Taranto Montemurro, L., Vicini, S., Wellman, A., Zanotti, L.
Published 2022